Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities

Sponsor
Thomas Jefferson University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06010355
Collaborator
(none)
120
1
3
15
8

Study Details

Study Description

Brief Summary

This clinical trial evaluates the impact of a culturally tailored educational video on the perceptions of lung cancer and lung cancer screening in vulnerable communities. Lung cancer is the most common cancer type. African-American communities have a higher rate than any other racial or ethnic group in the United States and accounts for the highest number of deaths among African-Americans. Lung cancer is in the top three causes of cancer death among Asian men and women. Research has shown that low-income, minority and immigrant individuals may be under resourced to make decisions about prevention programs and early detection measures for lung cancer. A culturally tailored educational video may be an effective method to help people learn about lung cancer, susceptibility toward lung cancer and lung cancer screening. This may increase lung cancer screening in vulnerable communities.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Discussion
  • Other: Media Intervention
  • Other: Interview
  • Other: Media Intervention
  • Other: Test
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. To understand barriers and opportunities for engaging three culturally distinct populations in lung cancer screening.

  2. To develop three culturally tailored educational videos about lung cancer and the benefits of lung cancer screening.

  3. To test the impact of the videos on susceptibility to lung cancer, knowledge of lung cancer screening, and intentions to undergo lung cancer screening in a diverse sample of at-risk individuals.

OUTLINE: Participants are assigned to 1 of 3 arms.

ARM I (AIM 1): Participants participate in a focus group over 1 hour in support of the development of a culturally tailored educational video on study.

ARM II (AIM 2): Participants watch a culturally tailored educational video over 3-5 minutes and then immediately undergo an interview in support of the refinement of a culturally tailored educational video on study.

ARM III (AIM 3): Participants watch a culturally tailored educational video over 3-5 minutes and complete a brief test pre- and post-video over 30 minutes on study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Breathe Easier, Philadelphia! Engaging Vulnerable Communities for Innovative Lung Cancer Care
Actual Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm I (Aim 1) (focus group)

Participants participate in a focus group over 1 hour in support of the development of a culturally tailored educational video on study.

Procedure: Discussion
Participate in focus groups
Other Names:
  • Discuss
  • Experimental: Arm II (Aim 2) (video, interview)

    Participants watch a culturally tailored educational video over 3-5 minutes and then immediately undergo an interview in support of the refinement of a culturally tailored educational video on study.

    Other: Media Intervention
    Watch culturally appropriate video

    Other: Interview
    Undergo interview

    Experimental: Arm III (Aim 3) (video, test)

    Participants watch a culturally tailored educational video over 3-5 minutes and complete a brief test pre- and post-video over 30 minutes on study.

    Other: Media Intervention
    Watch culturally appropriate video

    Other: Test
    Complete test

    Outcome Measures

    Primary Outcome Measures

    1. Change in knowledge about lung cancer screening [From baseline to endpoint, up to 1 year]

      McNemar's test and 95% confidence intervals (CI) used to compare the post-video knowledge response (single multiple choice correct/incorrect item) to the pre-video baseline knowledge response. Generalized estimating equations (GEE) linear and logistic regression models with main effect and interaction terms constructed to explore the potential effect modification between the video intervention and cultural subgroups.

    Secondary Outcome Measures

    1. Change in perceptions of susceptibility to lung cancer [From baseline to endpoint, up to 1 year]

      Paired t-tests and 95% CI used to compare the post-video perceived susceptibility scores (scored from four 4-point Likert scaled items to pre-video baseline scores. GEE linear and logistic regression models with main effect and interaction terms constructed to explore the potential effect modification between the video intervention and cultural subgroups.

    2. Change in intention to undergo lung cancer screening [From baseline to endpoint, up to 1 year]

      Paired t-tests and 95% CI used to compare the post-video intention to screen score (single 4-point Likert scaled item) to pre-video baseline scores. GEE linear and logistic regression models with main effect and interaction terms constructed to explore the potential effect modification between the video intervention and cultural subgroups.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • AIM 1: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening

    • AIM 2: Participants must be African American, Korean, or Chinese adults who have either: a history of smoking, a history of lung cancer, or who have undergone lung cancer screening

    • AIM 3: Those who are African American, Korean or Chinese, and are eligible for lung cancer screening, based on current screening guidelines: Current or former smokers who are between 50 and 80 years of age and who have smoked at least one pack a day for 20 years or two packs a day for 10 years

    Exclusion Criteria:
    • AIM 1: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening

    • AIM 2: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have one of the following: a history of smoking, a history of lung cancer, or have undergone lung cancer screening

    • AIM 3: Those excluded from participating include children; those who are not members of the African American, Chinese, or Korean community; those who do not have a history of smoking; those who have been diagnosed with lung cancer; those who have undergone lung cancer screening in the past

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Thomas Jefferson University Hospital Philadelphia Pennsylvania United States 19107

    Sponsors and Collaborators

    • Thomas Jefferson University

    Investigators

    • Principal Investigator: Amy R Leader, DrPH, MPH, Thomas Jefferson University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Thomas Jefferson University
    ClinicalTrials.gov Identifier:
    NCT06010355
    Other Study ID Numbers:
    • iRISID-2022-1320
    First Posted:
    Aug 24, 2023
    Last Update Posted:
    Aug 24, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 24, 2023